Table II.
Timeline of data collection in ORBIT-AF II
| Baseline | 6 mo | 12 mo | 18 mo | 24 mo | |
|---|---|---|---|---|---|
| Demographics, medical history, AF diagnosis, provider/site information | X | ||||
| Contraindications to oral anticoagulant therapy | X | ||||
| Vital signs, laboratory data, ECG, Holter, and echo data | X | X | X | X | X |
| Current pharmacotherapies (including INR monitoring) and adverse events | X | X | X | X | X |
| Temporary and permanent discontinuation of antithrombotic therapies | X | X | X | X | |
| Details of cardiac procedures | X | X | X | X | |
| Outcomes | X | X | X | X |
Abbreviations: ECG, Electrocardiogram; INR, international normalized ratio.